Search clinical trials for: Sublingual Buprenorphine

Total 760 results

Transcept Pharmaceuticals

Completed

Driving Performance After Middle of the Night Administration of 3.5 mg Zolpidem Tartrate Sublingual Tablet

Insomnia

Netherlands
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Rapid Outpatient Low-dose Initiation of Buprenorphine for OUD With Fentanyl Use (ROLDI)

Opioid Use Disorder
Seoul National University Hospital

Recruiting

Neuroimaging Study on the Effect of Transdermal Buprenorphine in Complex Regional Pain Syndrome Patients

Complex Regional Pain Syndromes

Korea, Republic of
Peter Rossing

Completed

Microalbuminuria and Allopurinol in Type 1 Diabetes (MIKAL)

Type 1 Diabetes | Diabetic Nephropathy

Denmark
National Institute on Drug Abuse (NIDA)
Mclean Hospital

Completed

Treatment Efficacy for Drug Abuse and AIDS Prevention - 1

Heroin Dependence | Cocaine-Related Disorders

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA); Columbia University

Completed

IV Cocaine Abuse: A Laboratory Model - 3

Cocaine-Related Disorders

United States
Tehran University of Medical Sciences

Completed

Buprenorphine in Acute Renal Colic Pain Management

Renal Colic | Acute Pain Management

Iran, Islamic Republic of
Norpharma A/S
Mundipharma Finland

Completed

Norspan® Patches Versus Tramadol in Subjects With Chronic, Moderate to Severe Osteoarthritis Pain in the Hip Knee and/or Lumbar Spine

Pain | Osteoarthritis

Finland
Frederick R. Ueland, M.D.
ArtemiLife

Active, not recruiting

Phase 1 Dose Escalation of ArtemiCoffee

Ovarian Cancer

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance Treatment of Opioid Dependence in Primary Care: A Randomized Clinical Trial

Opioid-Related Disorders | Heroin Dependence

United States
Georgetown University
National Institute on Drug Abuse (NIDA)

Terminated

The Effects of Opioid Taper on Opioid-Induced Hyperalgesia

Pain | Buprenorphine

United States
INSYS Therapeutics Inc

Completed

Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain

Pain

United States
University of Alabama at Birmingham
National Institute on Drug Abuse (NIDA)

Completed

Relapse Prevention to Reduce HIV Among Women Prisoners

HIV | Opioid Dependence
iX Biopharma Ltd.
Linear Clinical Research

Completed

A Pivotal Study of the Bioequivalence of Oral Viagra® and a Test Sublingual Sildenafil Wafer

Erectile Dysfunction

Australia
Biohaven Pharmaceuticals, Inc.

No longer available

Expanded Access Protocol of BHV-0223 for Patients With Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis | ALS | Lou Gehrig Disease | Lou Gehrig's Disease | Lou-Gehrigs Disease | Motor Neuron Disease, Amyotrophic Lateral Sclerosis
Braeburn Pharmaceuticals

Completed

Phase II Pharmacokinetics Study of CAM2038

Chronic Pain | Opioid Use Disorder

United States
Ain Shams University

Completed

Allopurinol in Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis

Endoscopic Retrograde Cholangiopancreatography
Shalvata Mental Health Center

Unknown

Study Assessing the Safety and Therapeutic Effect of Buprenorphine in MDD Patients

Depression

Israel
Aswan University Hospital

Not yet recruiting

Sublingual Versus Vaginal Misoprostol In Medical Treatment of Second Trimestric Missed Miscarriage

Miscarriage

Egypt
Virginia Commonwealth University
Indivior, PLC.

Withdrawn

Virginia Opioid Treatment-Emergency Department (VOT-ED)

Opioid Use Disorder
N4 Pharma UK Ltd.
BDD Pharma Ltd

Completed

Pharmacoscintigraphic Study to Evaluate Two Sildenafil Products

Erectile Dysfunction

United Kingdom
Bruyere Research Institute

Completed

The Preventative Role of Exogenous Melatonin Administration in Patients With Advanced Cancer Who Are at Risk of Delirium: a Feasibility Study

Cancer

Canada
Centre Hospitalier Universitaire de Nīmes

Recruiting

Add-on Buprenorphine at Analgesic Doses for the Treatment of Severe Suicidal Ideas During a Major Depressive Episode (BUPRIS)

Suicidal Ideation | Major Depressive Episode

France
Thomas Jefferson University
Chiesi Farmaceutici S.p.A.

Completed

Buprenorphine Pharmacometric Open Label Research Study of Drug Exposure (B-PHORE)

Neonatal Abstinence Syndrome | Neonatal Opiate Withdrawal Syndrome

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1

Substance-Related Disorders | Opioid-Related Disorders | Cocaine-Related Disorders

United States
University of Dundee
British Heart Foundation; NHS Tayside

Completed

Allopurinol as a Possible Oxygen Sparing Agent During Exercise in Peripheral Arterial Disease (APOSA-PAD)

Peripheral Arterial Disease

United Kingdom
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22

Opioid-Related Disorders | Cocaine-Related Disorders

United States
Brian Williams
University of Pittsburgh

Completed

4-drug Nerve Block Versus Plain Local Anesthetic for Knee and Hip Arthroplasty Analgesia in Veterans

Pain

United States
INSYS Therapeutics Inc

Completed

Long-term Safety and Efficacy Study of Fentanyl Sublingual Spray for the Treatment of Breakthrough Cancer Pain

Pain | Cancer

United States, India, Canada
Centre for Addiction and Mental Health
Reckitt Benckiser LLC

Completed

Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine ((IRLGREY-B))

Depression | Major Depressive Disorder

Canada
Korean Society of Hematology

Not yet recruiting

A Study of Treatment-free Remission in Chronic Phase Chronic Myeloid Leukemia (AsterA)

Chronic Myeloid Leukemia, Chronic Phase
Teva Pharmaceuticals USA

Completed

Buprenorphine 8 mg Sublingual Tablets Under Fasting Conditions

Healthy

United States
Université de Sherbrooke

Withdrawn

Allopurinol in Acute Gout

Gout
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2

Opioid-Related Disorders

United States
Tehran University of Medical Sciences

Completed

Efficacy of Buprenorphine for Treatment of Acute Pain

Acute Pain

Iran, Islamic Republic of
Washington University School of Medicine
Reckitt Benckiser LLC

Completed

Buprenorphine Used With Treatment Resistant Depression in Older Adults (IRLGreyB)

Depression | Major Depressive Disorder

United States
Teva Pharmaceuticals USA

Completed

Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis

Actinic Keratosis

United States
Maastricht University Medical Center

Active, not recruiting

Surgery Versus Combined Treatment With Curettage and Imiquimod for Nodular Basal Cell Carcinoma (SCIN)

Nodular Basal Cell Carcinoma

Netherlands
Andrea Campos-Serra
Corporacion Parc Tauli

Completed

Evaluation of Resuscitation Markers in Trauma Patients

Trauma | Hypovolemic Shock

Spain
Montefiore Medical Center
National Institute on Drug Abuse (NIDA)

Completed

Onsite Buprenorphine Treatment at Syringe Exchange Programs (O-BMT)

Opiate Addiction

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine's Dose Response Curve

Opioid-related Disorders

United States
Alkermes, Inc.

Completed

A Study of the Abuse Liability Potential of ALKS 5461 in Healthy, Non-Dependent, Recreational Opioid Users

Healthy

United States
Bayside Health

Completed

Immunological Mechanisms of Oralair® in Patients With Seasonal Allergic Rhinitis

Allergic Rhinitis

Australia
Apotex Inc.

Completed

A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Therapeutic Equivalence Study of Three Imiquimod Cream 5% Treatments for Patients With Actinic Keratosis

Actinic Keratosis
University Hospital, Ghent

Completed

Safety and Efficacy of Patient Controlled Analgesia Using the Sublingual Sufentanil Tablet System (SSTS) in a Fast Track Rehabilitation Program After Total Knee Arthroplasty (Zalviso)

Postoperative Pain

Belgium
Barretos Cancer Hospital
Farmoquimica S.A.

Completed

Randomized Clinical Trial Evaluating the Efficacy of Topical Imiquimod in High Grade Cervical Intraepithelial Lesions

Cervix Cancer | High Grade Intraepithelial Neoplasia

Brazil
Loyola University

Terminated

Sublingual Fentanyl and Procedural Burn Pain

Burn Pain

United States
INSYS Therapeutics Inc

Completed

Fentanyl Sublingual Spray in Treating Opioid-tolerant Cancer Patients With or Without Oral Mucositis

Pain | Unspecified Adult Solid Tumor, Protocol Specific | Mucositis

United States
Rhode Island Hospital
Brown University

Not yet recruiting

Identifying Optimal Buprenorphine Dosing for Opioid Use Disorder Treatment and Prevention of Overdose (Optimal Bup)

Opioid Use Disorder
Khon Kaen University

Recruiting

Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation Patients

Urinary Tract Infections | Kidney Transplantation | Klebsiella Infections | Escherichia Coli Infections | Anti-Infective Agents, Urinary

Thailand

Search clinical trials for: Sublingual Buprenorphine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jamaica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations